WHO ICTRP trial
JPRN-jRCT2080223237 · Takeda Development Center Americas, Inc. / CMIC Co., Ltd.
JPRN-jRCT2080223237 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080223237 |
|---|---|
| Primary sponsor | Takeda Development Center Americas, Inc. / CMIC Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Japan;Asia except Japan;North America;South America;Europe;Oceania |
| Interventions | investigational material(s) Generic name etc : INN of investigational material : ponatinib Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc… |
| Registration date | Aug 6, 2016 |
| Target size | 276 |
| Secondary IDs | NCT02467270;JapicCTI-163292 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: